In a rodent model of nonalcoholic steatohepatitis, for example, increased CP-I plasma and liver concentrations seem to stem from variations in multidrug resistance-associated protein expression rather than OATP1B (Chatterjee et al., 2021). The gene discussed is ABCC3; the disease is metabolic dysfunction-associated steatohepatitis.